The FDA has started a review of a novel MRI contrast agent developed by Bayer that can reduce levels of gadolinium, a rare earth metal that can have damaging health and environmental consequences.

Phase contrast microscopy is a white-light optical microscopy technique that relies on sample-induced phase changes in illumination light to generate images with more information than provided by ...